40 MARCUS DRIVE, MELVILLE, NY
Appointment of Donald J. Currie as Director of BioRestorative Therapies
Vice President of Research and Development Resignation - Mr. Silva
Amended material disclosure
Announces Reverse Stock Split
News
Amendments to Executive Employment Agreements for Key Officers
Material Contracts, Changes in Board, Management or Compensation
Executive Employment Agreement
Q1
FY 2025
Q3
Q2
FY 2024
Amended Annual Report
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
S-1
Direct Registration System
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement